In dystrophic hamsters losartan affects control of ventilation and dopamine D1 receptor density

Respiratory Physiology and Neurobiology

Volumn 173, Issue 1, 2010, Pages 71-78

  Schlenker, Evelyn H ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Angiotensin II receptor blocker; Dopamine D1 receptor; Hypercapnia; Hypoxia; Limb girdle muscular dystrophy

Indexed keywords

DOPAMINE 1 RECEPTOR; LOSARTAN;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREATHING; CONTROLLED STUDY; CORPUS STRIATUM; DYSTROPHY; HAMSTER; HEART WEIGHT; HYPERCAPNIA; HYPOXIA; LUNG VENTILATION; MALE; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; SOLITARY TRACT NUCLEUS; SYRIAN HAMSTER;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANOXIA; BODY WEIGHT; CORPUS STRIATUM; CRICETINAE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEART; HYPERCAPNIA; LOSARTAN; MALE; MESOCRICETUS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; ORGAN SIZE; PLETHYSMOGRAPHY; PULMONARY VENTILATION; RECEPTORS, DOPAMINE D1; SOLITARY NUCLEUS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 77955424725     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2010.06.012     Document Type: Article

References (53)

1. Allen A.M. Angiotensin AT1 receptor-mediated excitation of rat carotid body chemoreceptor afferent activity. J. Physiol. 1998, 510.3:773-781.
2. Ambur L.C., Schlenker E.H. Losartan affects tyrosine hydroxylase protein expression in the A2 Area and hypoglossal nucleus of normal and dystrophic hamsters. FASEB J. 2009, 23:791-796.
3. Ballanyi K., Lalley P.M., Hoch B., Richter D.W. cAMP-dependent reversal of opioid- and prostaglandin-mediated depression of the isolated respiratory network in newborn rats. J. Physiol. 1997, 504:127-134.
4. Bourassa E.A., Speth R.C. Water deprivation increases angiotensin-converting enzyme but not AT1 receptor expression in brainstem and paraventricular nucleus of the hypothalamus of the rat. Brain Res. 2010, 1319:83-91.
5. Clare J.L., Andrea A.D., Jillian M.P., Robert Di N., Claire L.C., Margaret J.M., Lea M.D.D. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodellomg in rat myocardium. Clin. Exp. Pharmacol. Physiol. 2004, 31:512-517.
6. Cohn R.D., van Erp C., Habashi J.P., Soleimani A.A., Klein E.C., Lisi M.T., Gamradt M., ap Rhys C.M., Holm T.M., Loeys B.L., Ramirez F., Judge D.P., Ward C.W., Dietz H.C. Angiotensin II type 1 receptor blockade attenuates TGF-[beta]-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 2007, 13:204-210.
7. Czyrak A., Chocyk A., Mackowiak M., Fijal K., Wedzony K. Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study. Mol. Brain Res. 2000, 85:209-217.
8. Dixon I.M.C., Hao J., Reid N.L., Roth J.C. Effect of chronic AT1 receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters. Cardiovasc. Res. 2000, 46:286-297.
9. Dixon I.M.C., Ju H., Reid N.L., Scammell-La Fleur T., Werner J.P., Jasmin G. Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan. J. Mol. Cell. Cardiol. 1997, 29:1837-1850.
10. Eckardt L., Harzer W. Facial structure and functional findings in patients with progressive muscular dystrophy (Duchenne). Am. J. Orthod. Dentofac. Orthop. 1996, 110:185-190.
11. Escobales N., Crespo M.J. Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress. Vasc. Pharmacol. 2006, 44:22-28.
12. Evans K.C., Shea S.A., Saykin A.J. Functional MRI localisation of central nervous system regions associated with volitional inspiration in humans. J. Physiol. 1999, 520:383-392.
13. Guglieri M., Magri F., Comi G.P. Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: boundaries and contiguities. Clin. Chim. Acta 2005, 361:54-75.
14. Heydemann A., Huber J.M., Demonbreun A., Hadhazy M., McNally E.M. Genetic background influences muscular dystrophy. Neuromuscular Disord. 2005, 15:601-609.
15. Jennings D.B., Lockett H.J. Angiotensin stimulates respiration in spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R1125-R1133.
16. Kefi M., Amouri R., Driss A., Hamida C.B., Hamidaa M.B., Kunkel L.M., Hentati F. Phenotype and sarcoglycan expression in Tunisian LGMD 2C patients sharing the same del521-T mutation. Neuromuscular Disord. 2003, 13:779-787.
17. Khan F., Spicarova Z., Zelenin S., Holtback U., Scott L., Aperia A. Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 2008, 295:F1110-1116.
18. Kirschner J., Carsten M. The congenital and limb-girdle muscular dystrophies. Arch. Neurol. 2004, 61:189-199.
19. 2 reactivity. Respir. Physiol. Neurobiol. 2004, 139:247-262.
20. Lambert C., Massillon Y., Meloche S. Upregulation of cardiac angiotensin II AT1 receptors in congenital cardiomyopathic hamsters. Circ. Res. 1995, 77:1001-1007.
21. Leung P.S., Lam S.Y., Fung M.L. Chronic hypoxia upregulates the expression and function of AT(1) receptor in rat carotid body. J. Endocrinol. 2000, 167:517-524.
22. Li A., Emond L., Nattie E. Brainstem catecholaminergic neurons modulate both respiratory and cardiovascular function. Adv. Exp. Med. Biol. 2008, 605:371-376.
23. Macova M., Pavel J., Saavedra J.M. A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH. Brain Res. 2009, 1250:130-140.
24. Marcus N.J., Li Y.-L., Bird C.E., Schultz H.D., Morgan B.J. Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor. Respir. Physiol. Neurobiol. 2010, 171:36-45.
25. Mertens B., Vanderheyden P., Michotte Y., Sarre S. Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum. Neuropharmacology 2010, 58:1038-1044.
26. Mifflin S.W. Arterial chemoreceptor input to nucleus tractus solitarius. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1992, 263:R368-R375.
27. Morin L.P., Wood R.I. A Stereotaxic Atlas of the Golden Hamster Brain 2001, Academic Press/Harcourt Science and Technology Co., San Diego, CA.
28. 2 dialysis in nucleus tractus solitarius region of rat increases ventilation in sleep and wakefulness. J. Appl. Physiol. 2002, 92:2119-2130.
29. Nigro V., Piluso G., Belsito A., Politano L., Puca A.A., Papparella S., Rossi E., Viglietto G., Esposito M.G., Abbondanza C., Medici N., Molinari A.M., Nigro G., Puca G.A. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35kDa glycoprotein. Hum. Mol. Genet. 1996, 5:1179-1186.
30. Olsson M., Annerbrink K., Hedner J., Eriksson E. Intracerebroventricular administration of the angiotensin II receptor antagonist saralasin reduces respiratory rate and tidal volume variability in freely moving Wistar rats. Psychoneuroendocrinology 2004, 29:107-112.
31. Pawlak R., Napiorkowska-Pawlak D., Takada Y., Urano T., Nagai N., Ihara H., Takada A. The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors. Brain Res. Bull. 2001, 54:689-694.
32. Politano L., Nigro V., Passamano L., Petretta V., Comi L.I., Papparella S., Nigro G., Rambaldi P.F., Raia P., Pini A., Mora M., Giugliano M.A., Esposito M.G., Nigro G. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscular Disord. 2001, 11:178-185.
33. Pulgar V.M., Hong J.K.-s., Jessup J.A., Massmann A.G., Diz D.I., Figueroa J.P. Mild chronic hypoxemia modifies expression of brain stem angiotensin peptide receptors and reflex responses in fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R446-R452.
34. Ragette R., Mellies U., Schwake C., Voit T., Teschler H. Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 2002, 57:724-728.
35. Rey P., Lopez-Real A., Sanchez-Iglesias S., Muñoz A., Soto-Otero R., Labandeira-Garcia J.L. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. Neurobiol. Aging 2007, 28:555-567.
36. Sakamoto A., Ono K., Abe M., Jasmin G., Eki T., Murakami Y., Masaki T., Toyo-oka T., Hanaoka F. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13873-13878.
37. Saylor D.L., Perez R.A., Absher D.R., Baisden R.H., Woodruff M.L., Joyner W.L., Rowe B.P. Angiotensin II binding sites in the hamster brain: location and subtype distribution. Brain Res. 1992, 595:98-106.
38. Schlenker E.H. An evaluation of ventilation in dystrophic Syrian hamsters. J. Appl. Physiol. 1984, 56:914-921.
39. Schlenker E.H., Burbach J.A. Elevated tumor necrosis factor-alpha like antigen levels (TNFL) in brains of dystrophic hamsters. Soc. Neurosci. Abstr. 1993, 18:483.
40. Schlenker E.H., Burbach J.A. Thyroxine affects ventilation, lung morphometry, and necrosis of diaphragm in dystrophic hamsters. Am. J. Physiol. 1995, 268:R779-R785.
41. Schlenker E.H., Richards A. Effects of long term losartan treatment on D2 receptor modulation of breathing in the dystrophic hamster in air and following intermittent hypoxic bouts. FASEB J. 2008, 22:1232-1233.
42. Schultz H.D., Li Y.L. Carotid body function in heart failure. Respir. Physiol. Neurobiol. 2007, 157:171-185.
43. Seltzer A., Bregonzio C., Armando I., Baiardi G., Saavedra J.M. Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Res. 2004, 1028:9-18.
44. Siala O., Fatma F.K., Louhichi N., Salem I.H., Gribaa M., Elghzel H., Saad A., Triki C., Fakhfakh F. Molecular prenatal diagnosis of muscular dystrophies in Tunisia and postnatal follow-up role. Genet. Test. 2008, 12:581-586.
45. Stragier B., Sarre S., Vanderheyden P., Vauquelin G., Fournie-Zaluski M.-C., Ebinger G., Michotte Y. Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat. J. Neurochem. 2004, 90:1251-1257.
46. Sun G., Haginoya K., Dai H., Chiba Y., Uematsu M., Hino-Fukuyo N., Onuma A., Iinuma K., Tsuchiya S. Intramuscular renin-angiotensin system is activated in human muscular dystrophy. J. Neurol. Sci. 2009, 280:40-48.
47. Tham M., Sim M.K., Tang F.R. Location of renin-angiotensin system components in the hypoglossal nucleus of the rat. Regul. Peptides 2001, 101:51-57.
48. Varney A.A., Schlenker E.H. Thyroid status affects 5-HT2A receptor modulation of breathing before, during, and following exposure of hamsters to acute intermittent hypoxia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R2070-R2080.
49. Vitiello C., Faraso S., Sorrentino N., Di Salvo G., Nusco E., Nigro G., Cutillo L., Calabrò R., Auricchio A., Nigro V. Disease rescue and increasedlifespan in amodel of cardiomyopathy and muscular dystrophy by combined AAV treatments. PLoS One 2009, 4:e5051.
50. Weiner D.M., Levey A.I., Sunahara R.K., Niznik H.B., O'Dowd B.F., Seeman P., Brann M.P. D1 and D2 dopamine receptor mRNA in rat brain. PNAS 1991, 88:1859-1863.
51. Yamauchi M., Dostal J., Strohl K.P. Acetazolamide protects against posthypoxic unstable breathing in the C57BL/6J mouse. J. Appl. Physiol. 2007, 103:1263-1268.
52. Yang S.N., Lippoldt A., Jansson A., Phillips M.I., Ganten D., Fuxe K. Localization of angiotensin II AT1 receptor-like immunoreactivity in catecholaminergic neurons of the rat medulla oblongata. Neuroscience 1997, 81:503-515.
53. Zhu G.-Q., Gao L., Patel K.P., Zucker I.H., Wang W. ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. J. Appl. Physiol. 2004, 97:1746-1754.